Laboratory Capacity for Antimicrobial Susceptibility Surveillance of Neisseria gonorrhoeae—District of Columbia, 2007–2012

Garrett, Tiana A.; Davies-Cole, John; Furness, Bruce W.

doi:10.1097/olq.0000000000000304

Cited by 4 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, most laboratories conducted serological testing for syphilis (50). A survey of laboratories in the District of Columbia that reported gonorrhea results to the health department demonstrated that among laboratories that conducted gonorrhea cultures, only one third performed antibiotic susceptibility testing (51). A study of clinical laboratories in California reported that gonorrhea culture testing has substantially decreased and gonorrhea and chlamydia tests performed using NAAT have increased over time (52).…”

Section: Current Practice On Selected Clinical Services In the Unitedmentioning

confidence: 99%

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Barrow¹,

Ahmed²,

Bolan³

et al. 2020

MMWR Recomm. Rep.

View full text Add to dashboard Cite

This report (hereafter referred to as STD QCS) provides CDC recommendations to U.S. health care providers regarding quality clinical services for sexually transmitted diseases (STDs) for primary care and STD specialty care settings. These recommendations complement CDC's Sexually Transmitted Diseases Treatment Guidelines, 2015 (hereafter referred to as the STD Guidelines), a comprehensive, evidence-based reference for prevention, diagnosis, and treatment of STDs. STD QCS differs from the STD Guidelines by specifying operational determinants of quality services in different types of clinical settings, describing on-site treatment and partner services, and indicating when STD-related conditions should be managed through consultation with or referral to a specialist. These recommendations might also help in the development of cliniclevel policies (e.g., standing orders, express visits, specimen panels, and reflex testing) that can facilitate implementation of the STD Guidelines. CDC organized the recommendations for STD QCS into eight sections: 1) sexual history and physical examination, 2) prevention, 3) screening, 4) partner services, 5) evaluation of STD-related conditions, 6) laboratory, 7) treatment, and 8) referral to a specialist for complex STD or STD-related conditions. CDC developed the recommendations by synthesizing relevant, evidence-based guidelines and recommendations issued by other experts; reviewing current practice in the United States; soliciting Delphi ratings by subject matter experts on STD care in primary care and STD specialty care settings; discussing the scientific evidence supporting the proposed recommendations at a consultation meeting of experts and institutional stakeholders held November 20, 2015, in Atlanta, Georgia; conducting peer reviews of draft recommendations and supporting evidence; and discussing draft recommendations and supporting evidence during meetings of the CDC/Health Resources and Services Administration Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment STD Work Group. These recommendations are intended to help health care providers in primary care or STD specialty care settings offer STD services at their clinical settings and to help the persons seeking care live safer, healthier lives by preventing and treating STDs and related complications.

show abstract

Section: Current Practice On Selected Clinical Services In the Unitedmentioning

confidence: 99%

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Barrow¹,

Ahmed²,

Bolan³

et al. 2020

MMWR Recomm. Rep.

View full text Add to dashboard Cite

show abstract

“…Current clinical practice uses mostly nucleic acid amplification tests to detect N. gonorrhoeae and not culture-based methods ( 4 ). Although those tests yield better clinical outcomes, they do not provide useful antimicrobial drug susceptibility data.…”

mentioning

confidence: 99%

“…Although those tests yield better clinical outcomes, they do not provide useful antimicrobial drug susceptibility data. Therefore, factors associated with antimicrobial drug resistance in the general community are not routinely available ( 4 , 5 ).…”

mentioning

confidence: 99%

Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA

Bhatti¹,

Allan‐Blitz²,

Castrejon³

et al. 2017

Emerg. Infect. Dis.

View full text Add to dashboard Cite

show abstract

“…Usually, men who have sex with men (MSM) are the core high risk population with high incidence of gonorrhea in those countries. [21][22][23] We con rmed that the availability of laboratory tests of NG is related to case reporting of gonorrhea. The distribution of hospitals with gonorrhea case reporting was consistent with that of hospitals where laboratory tests were available.…”

Section: Discussionmentioning

confidence: 89%

Availability of laboratory diagnosis of gonorrhoea and its meaning in case reporting in Shandong province, China

Chen¹,

Gan²,

Liu

2020

Preprint

View full text Add to dashboard Cite

Abstract Background The aim of this study is to understand the availability of laboratory diagnosis of gonorrhoea in Shandong province and its meaning in case reporting. Methods Two surveys were conducted among hospitals providing clinical services for sexually transmitted infection(STI) in Shandong Province in 2012 and 2018. The availability of laboratory tests for Neisseria gonorrhoeae (NG) and distribution of reported gonorrhea cases were compared among different hospitals provided clinical services for STI in Shandong province. Descriptive analysis and Chi-square were used for statistical analysis. Results Smear, culture and PCR tests for NG were used among 301(74.69%), 123(30.52%), 43(10.67%) hospitals in 2012 and 356(74.48%), 176(36.82%) and 73(15.27%) hospitals in 2018, respectively. Significant differences were observed in the availability of smear among hospitals at different levels (X2 = 12.159, p = 0.000) and with different affiliations(X2 = 4.551, p = 0.033) in 2018. Significant differences were observed in the availability of culture and PCR tests among hospitals at different levels both in 2012 (X2 = 34.532, p = 0.000; X2 = 7.380, p = 0.007) and 2018 (X2 = 49.820, p = 0.000; X2 = 21.658, p = 0.000). The availability of culture and PCR tests for NG among hospitals in 2018 was higher than that in 2012 (X2 = 3.870, p = 0.049; X2 = 4.050, p = 0.044). More hospitals reported gonorrhea cases in 2018 than in 2012 (X2 = 6.768, p = 0.009). A significant difference was observed in distribution of case reporting among hospitals at different levels in 2018 (X2 = 6.975, p = 0.008) and among different types of hospitals both in 2012 (X2 = 52.362, p = 0.000) and 2018 (X2 = 74.478, p = 0.000). Conclusion Poor availability of NG laboratory tests affects case reporting and is a crucial reason leading to high sex ratio and underreporting of gonorrhea cases in Shandong province. Trial registration Not applicable

show abstract

Laboratory Capacity for Antimicrobial Susceptibility Surveillance of Neisseria gonorrhoeae—District of Columbia, 2007–2012

Abstract: We report a low prevalence of laboratories performing AST because of multiple barriers. State-specific strategies addressing these barriers are needed to improve detection of antibiotic-resistant gonorrhea stains circulating among the population.

Cited by 4 publications

References 7 publications

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Recommendations for Providing Quality Sexually Transmitted Diseases Clinical Services, 2020

Epidemiology of Neisseria gonorrhoeae Gyrase A Genotype, Los Angeles, California, USA

Availability of laboratory diagnosis of gonorrhoea and its meaning in case reporting in Shandong province, China

Contact Info

Product

Resources

About